ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,517 | -3.3% | 3,441 | +51.3% | 0.00% | 0.0% |
Q2 2023 | $17,085 | +27456.5% | 2,275 | -83.4% | 0.00% | -50.0% |
Q1 2023 | $62 | +376.9% | 13,694 | +1021.5% | 0.00% | +100.0% |
Q4 2022 | $13 | -100.0% | 1,221 | -86.7% | 0.00% | 0.0% |
Q3 2022 | $88,000 | +54.4% | 9,200 | +29.8% | 0.00% | 0.0% |
Q2 2022 | $57,000 | +18.8% | 7,090 | +147.6% | 0.00% | – |
Q1 2022 | $48,000 | -47.8% | 2,864 | -33.0% | 0.00% | -100.0% |
Q4 2021 | $92,000 | -12.4% | 4,277 | +200.1% | 0.00% | -33.3% |
Q3 2021 | $105,000 | +18.0% | 1,425 | -12.6% | 0.00% | +50.0% |
Q2 2021 | $89,000 | +58.9% | 1,630 | +114.2% | 0.00% | +100.0% |
Q1 2021 | $56,000 | -52.5% | 761 | -44.6% | 0.00% | -75.0% |
Q4 2020 | $118,000 | +96.7% | 1,373 | -13.3% | 0.00% | +300.0% |
Q3 2020 | $60,000 | – | 1,583 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $109,318,155 | 33.89% |
Vivo Capital, LLC | 4,220,048 | $47,560 | 5.48% |
Logos Global Management LP | 2,349,600 | $26,479,992 | 3.10% |
Samsara BioCapital, LLC | 262,786 | $2,961,598 | 0.64% |
Orbimed Advisors | 2,871,000 | $32,356,170 | 0.62% |
Pier Capital, LLC | 271,848 | $3,063,727 | 0.50% |
Cormorant Asset Management, LP | 612,079 | $6,898 | 0.46% |
Nan Fung Group Holdings Ltd | 41,950 | $472,777 | 0.33% |
Artal Group S.A. | 500,000 | $5,635 | 0.32% |
Redmile Group, LLC | 607,470 | $6,846,187 | 0.28% |